||This article may require cleanup to meet Wikipedia's quality standards. (March 2010)|
Kevin Kimberlin is chairman of Spencer Trask & Co, an advanced technology venture capital firm. Kimberlin has distinguished himself by backing “obsessive missionaries,” such as Jonas Salk, Walter Gilbert, and John Wennberg.
In 1982, Kimberlin invested in and structured the first outside financing for Millicom, which helped the company form its joint venture called Racal—Millicom -- renamed Vodafone Group Plc. Vodafone serves more than 400 million mobile phone users globally.
Kevin Kimberlin co-founded Ciena Corporation with Dr. David Huber in November 1993. Ciena invented the dual-stage optical amplifier and Dense Wave Division Multiplexing, two foundations of the Internet. That year, it was said that the dual stage optical amplifier can be compared in importance to the integrated circuit. DWDM is the basis of all high-capacity optical fiber systems in metro, regional and long distance networks around the world.
Prior to its public offering, Kimberlin was the sole General Partner of Next Level Communications, a broadband access leader. Kimberlin guided Next Level through its IPO, achieving a market cap of $17 billion before it was acquired by Motorola in 2002.
He then co-founded Myriad Genetics, the first human genome company, with Nobel Prize winner Dr. Walter Gilbert, Peter Meldrum, and Dr. Mark Skolnick, who with several colleagues devised the gene-mapping technique that catalyzed the Human Genome Project. Myriad Genetics received international acclaim by discovering the breast cancer gene, BRCA1. With this find, Dr. James D. Watson, co-discoverer of the double-helix structure of DNA, said there is “no more exciting story in medical science.”
Kimberlin also co-founded the first stem cell company, Osiris Therapeutics. Osiris uses adult stem cells to bypass the ethical and moral controversy surrounding this scientific breakthrough. A leader in stem cell research, Osiris received the world's first regulatory approval for stem cell-based therapy in 2012. By regenerating a variety of human tissue, Osiris is treating acute myocardial infarction, Type I diabetes, Graft versus Host Disease, Crohn’s Disease, exposure to radiation, and arthritis.
Kimberlin helped launch Health Dialog based on the research of John Wennberg whose clinical studies precipitated the Affordable Care Act. By putting patients in charge of their medical decisions, Health Dialog lowers cost and improves quality of health care for 18 million people. Once it grew into one of the fastest growing private companies in America, Health Dialog was acquired by British United Provident Association (BUPA) for $775 million.
Kimberlin acquired 1,082,490 shares of Organova stock (ONVO) in March, 2012, a development stage 3D bio-printing company spearheading the development of tissue assays for pharmaceutical and cosmetics testing. The company's goal is to eventually "print" human organs for transplant beginning with the liver.
Philanthropic endeavors support science, education and creativity, including the Audubon Society, the Boys and Girls Club, Harvard University, and Yaddo, the artist community founded 100 years ago by Mr. Spencer Trask and his wife. Kimberlin serves as a Director of Yaddo.
- Business Week, Executive Profile
- Gordon, Joanne and Mary Beth Grover. “200 Best Small Companies: Celestial Cast of Characters.” Forbes 2 November 1998: 192.
- “History – Vodafone.” Welcome to Vodafone – Vodafone. 2007. Vodafone Group Plc. 21 June 2007, http://www.vodafone.com/start/about_vodafone/who_we_are/history.html
- Ciena S-1 filing, December 12, 1996. Page 46, footnote 17 
- Dark Fiber, Dumb Network, George Gilder / MCI ID: 409-1174 INTO THE FIBERSHPHERE 
- Announcement of the induction of Steven Alexander as a IEEE Fellow and recipient of the IEEE Industrial Innovation Award 
- Next Level Communications acquired by Motorola
- Hero With Something to Prove, Los Angeles Times, SHERYL STOLBERG, p.1, March 7, 1993
- Global Health Reporting: AIDS
- Breakthrough: The race to find the Breast Cancer Gene
- Waldholz, Michael. “Scientists Say They’ve Found Gene That Causes Breast Cancer --- Study Could Lead to Test For Those at High Risk Of Inheriting Disease.” Wall Street Journal [New York] 14 Sept. 1994: B7
- Brown, Phyllida. “Breast Cancer: a lethal inheritance—Geneticists are close to identifying a gene that can lead to hereditary breast cancer. But at first this breakthrough could raise more problems than it solves.” New Scientist 18 Sept. 1993: 34.
- Pollack, Andrew (17 May 2012). "A Stem-Cell-Based Drug Gets Approval in Canada". The New York Times.
- JDRF Partners with Osiris on Phase II Trial of Immunomodulatory Cell Therapy for Type 1 Diabetes
- Osiris Therapeutics Reports Positive Results for Prochymal as a Rescue Agent in Pediatric Patients with End-Stage Graft vs. Host Disease
- Osiris receives FDA fast track status for Prochymal in treat Crohn's disease
- Washington Post, 1/7/08, U.S. Deal Boosts Radiation Drug, Zachary Goldfarb.
- Chondrogen Phase 1/2 Data
- Dartmouth Exemplifies Academics Informing Policy, Says Economist Peter Orszag
- New York Times, 12/24/98
- Spencer Trask & Co.
- Greenwich Magazine - Dynamic Duo
- BER Business Times - The New Face of Philanthropy